Literature DB >> 10496825

Admission for and mortality from primary venous thromboembolism in women of fertile age in Denmark, 1977-95.

L Mellemkjaer1, H T Sørensen, L Dreyer, J Olsen, J H Olsen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10496825      PMCID: PMC314208          DOI: 10.1136/bmj.319.7213.820

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Mortality from venous thromboembolism and myocardial infarction in young adults in England and Wales.

Authors:  S H Thomas
Journal:  Lancet       Date:  1996-08-10       Impact factor: 79.321

2.  Mortality from venous thromboembolism and myocardial infarction in young women in the Netherlands.

Authors:  J P Vandenbroucke; K W Bloemenkamp; F M Helmerhorst; F R Rosendaal
Journal:  Lancet       Date:  1996-08-10       Impact factor: 79.321

3.  Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.

Authors: 
Journal:  Lancet       Date:  1995-12-16       Impact factor: 79.321

4.  Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.

Authors:  H Jick; S S Jick; V Gurewich; M W Myers; C Vasilakis
Journal:  Lancet       Date:  1995-12-16       Impact factor: 79.321

5.  Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women.

Authors:  W O Spitzer; M A Lewis; L A Heinemann; M Thorogood; K D MacRae
Journal:  BMJ       Date:  1996-01-13
  5 in total
  7 in total

1.  The third generation oral contraceptive controversy. The evidence shows they are less safe than second generation pills.

Authors:  P A O'Brien
Journal:  BMJ       Date:  1999-09-25

2.  Sex disparities in hospitalization and mortality rates for venous thromboembolism.

Authors:  Sola Mansour; Ghazi Alotaibi; Cynthia Wu; Khalid Alsaleh; Michael Sean McMurtry
Journal:  J Thromb Thrombolysis       Date:  2017-08       Impact factor: 2.300

3.  Mortality from venous thromboembolism in young Swedish women and its relation to pregnancy and use of oral contraceptives--an approach to specifying rates.

Authors:  Eva Samuelsson; Karin Hedenmalm; Ingemar Persson
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 4.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

5.  Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: analysis of general practice research database.

Authors:  R D Farmer; T J Williams; E L Simpson; A L Nightingale
Journal:  BMJ       Date:  2000 Aug 19-26

6.  Time trends for pulmonary embolism incidence in Greece.

Authors:  Dimitrios G Raptis; Konstantinos I Gourgoulianis; Zoe Daniil; Foteini Malli
Journal:  Thromb J       Date:  2020-01-23

7.  Temporal trends in pulmonary embolism prevalence in Greece during 2013-2017.

Authors:  Ioannis C Lampropoulos; Dimitrios G Raptis; Zoe Daniil; Sotirios K Tasoulis; Vassilis P Plagianakos; Foteini Malli; Konstantinos I Gourgoulianis
Journal:  BMC Public Health       Date:  2021-03-21       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.